Riccardo Cortese

USPTO Granted Patents = 24 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 95(Granted Patents)

Location History:

Basel, IT (2022)
Basel, CH (2020 - 2023)
Rome, IT (1999 - 2024)

Company Filing History:

13 out of 531

Glaxosmithkline Biologicals Sa

patents

5 out of 47

Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa

patents

2 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

4. 1 out of 1

Istituto Di Recerche Di Biologia Molecolare P. Angeletti S.p.a.

patent

5. 1 out of 8

Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.p.a.

Sabin Vaccine Institute

patent

8. 1 out of 77

University of Copenhagen

patents

9. 1 out of 1

Instituto Di Recerche Di Biologia Molecolare P. Angeletti S.p.a.

patent

10. 1 out of 2,405

Merck Sharp + Dohme Corp.

patents

11. 1 out of 1

Istituto Di Recerche Di Biologia Moleculare P. Angeletti S.p.a.

patent

where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...

24 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11913013 - Chimpanzee adenoviral vector-based filovirus vaccines (2024-02-27),

2. 11701422 - Expression systems (2023-07-18),

3. 11498956 - Fusion peptides with antigens linked to short fragments of invariant chain(CD74) (2022-11-15),

4. 11278614 - Poxviral vaccines (2022-03-22),

5. 11254711 - Adenovirus polynucleotides and polypeptides (2022-02-22),

6. 11254710 - Adenovirus polynucleotides and polypeptides (2022-02-22),

7. 11214599 - Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof (2022-01-04),

8. 10588961 - Poxviral vaccines (2020-03-17),

9. 10584355 - Chimpanzee adenoviral vector-based filovirus vaccines (2020-03-10),

10. 10576143 - Poxviral vaccines (2020-03-03),

11. 10544192 - Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof (2020-01-28),

12. 9895431 - Simian adenoviral vectors encoding malaria antigen (2018-02-20),

13. 9718863 - Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof (2017-08-01),

14. 9526777 - Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein (2016-12-27),

15. 8142794 - Hepatitis C virus vaccine (2012-03-27),

Title: The Innovative Mind of Riccardo Cortese

Introduction: Riccardo Cortese, a visionary inventor hailing from Rome, Italy, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Riccardo Cortese holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing his diverse range of expertise and forward-thinking approach to problem-solving.

Career Highlights: With a career spanning over two decades, Cortese has worked with leading tech companies and research institutions, spearheading projects that have revolutionized industries and improved the quality of life for many around the world.

Collaborations: Throughout his career, Riccardo Cortese has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and creativity that has led to the development of cutting-edge technologies and solutions.

Conclusion: Riccardo Cortese's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, solidifying his legacy as a true pioneer in the world of technology.

This text is generated by artificial intelligence and may not be accurate.